Antibody COVID-19 Therapies Back in China Spotlight Amid Infection Surge

 
• By Dexter Jie Yan
  
China biotechs work on antibody COVID-19 therapies
Three China-based biotechs are still chasing antibody COVID-19 therapies • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia